Q2 2009

Source filing unavailable

Q2 2009 · —

Revenue

$165.73M

no prior Q2 2008 on file

Net Income

$11.23M

no prior Q2 2008 on file

EPS Diluted

$0.38

no prior Q2 2008 on file

Operating Income$23,905,000—

Margins · derived

Operating margin14.4%

Net margin6.8%

Same quarter

no prior Q2 2008 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR